Methadone related deaths compared to all prescription related deaths

Forensic Science International

Volumn 257, Issue , 2015, Pages 347-352

  Lev, Roneet ^a   Petro, Sean ^b   Lee, Ariella ^a,b,c,d   Lee, Oren ^a,b,c,d   Lucas, Jonathan ^c   Castillo, Edward M ^d   Egnatios, Jeremy ^d   Vilke, Gary M ^d  

^a SCRIPPS MERCY HOSPITAL   (United States)

^b LAC USC MEDICAL CENTER   (United States)

^c San Diego County Medical Examiner's Office   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CURES; Methadone; Opioid treatment; Overdose; PDMP; Prescription deaths

Indexed keywords

ALCOHOL; ALPRAZOLAM; AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; COCAINE; CODEINE; DIAMORPHINE; DIAZEPAM; DIPHENHYDRAMINE; DOXEPIN; FLUOXETINE; GABAPENTIN; HYDROCODONE; HYDROMORPHONE; LAMOTRIGINE; METHADONE; METHAMPHETAMINE; MORPHINE; NORTRIPTYLINE; OPIATE; OXYCODONE; PHENYTOIN; QUETIAPINE; SERTRALINE; TRAMADOL; TRAZODONE; NARCOTIC AGENT;

ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ABUSE; DRUG MONITORING; DRUG TRAFFIC; DRUG UTILIZATION; FEMALE; HUMAN; MALE; MEDICAL SPECIALIST; METHADONE RELATED DEATH; MORTALITY; OBSERVATIONAL STUDY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; TOXICOLOGY; VERY ELDERLY; CALIFORNIA; DRUG CONTROL; DRUG DEPENDENCE TREATMENT; DRUG MISUSE; DRUG OVERDOSE; EPIDEMIOLOGY; FACTUAL DATABASE; INFORMATION DISSEMINATION; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CALIFORNIA; DATABASES, FACTUAL; DRUG AND NARCOTIC CONTROL; DRUG OVERDOSE; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INFORMATION DISSEMINATION; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; PRESCRIPTION DRUG MISUSE; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84945966321     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2015.09.021     Document Type: Article

References (21)

1. World Drug Report 2014, United Nations publication, sales no. E.14.XI.7, https://www.unodc.org/documents/wdr2014/World_Drug_Report_2014_web.pdf. CrimeUNOoDa (Ed.).
2. McCabe S.E., Boyd C.J., Teter C.J. Medical use, illicit use, and diversion of abusable prescription drugs. J. Am. Coll. Health 2006, 54:269-278.
3. Manubay J.M., Muchow C., Sullivan M.A. Prescription drug abuse: epidemiology, regulatory issues, chronic pain management with narcotic analgesics. Prim. Care 2011, 38. 71-vi.
4. Irvine J.M., Hallvik S.E., Hildebran C., Marino M., Beran T., Deyo R.A. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians. J Pain 2014, 15:747-755.
5. Prescription Drug Overdose in the United States CDC - Facts-Drug Overdose-Home and Recreational Safety- 2015, Injury Center: Center for Disease Control and Prevention, http://www.cdc.gov/drugoverdose/.
6. Methadone Mortality 2010, Center for Substance Abuse Treatment, Washington, DC, Substance Abuse and Mental Health Services Administration.
7. Jones C.M., Lurie P., Woodcock J. Addressing prescription opioid overdose: data support a comprehensive policy approach. JAMA 2014, 1733-1734.
8. Ballantyne J.C., Kolodny A. Preventing prescription opioid abuse. JAMA 2015, 1059.
9. Controlled Substance Utilization Review and Evaluation System (CURES) 2015, Prescription Drug Monitoring Program (PDMP), California, State of California Department of Justice and Office of the Attorney General. https://oag.ca.gov/cures-pdmp.
10. Hildebran C., Cohen D.J., Irvine J.M., et al. How clinicians use prescription drug monitoring programs: a qualitative inquiry. Pain Med. 2014, 15:1179-1186.
11. Smith R.J., Kilaru A.S., Perrone J., et al. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?. Pain Med. 2015.
12. D. Hoyert, NCHS Data Brief 90, Number 88, March 2012. http://www.cdc.gov/nchs/data/databriefs/db88.pdf.
13. Bureau of Justice Assistance. Guidance on PDMP Best Practices 2014, http://www.pdmpexcellence.org/sites/all/pdfs/Brandeis_COE_Guidance:on_Unsolicited_Reporting_final.pdf. Brandeis (Ed.).
14. Mack K.A. Drug-induced deaths-United States, 1999-2010. MMWR Surveill. Summ. 2013, 161-163.
15. Petrushevska T., Jakovski Z., Poposka V., Stefanovska V.V. Drug-related deaths between 2002 and 2013 with accent to methadone and benzodiazepines. J. Forensic Leg. Med. 2015, 31:12-18.
16. Ray W.A., Chung C.P., Murray K.T., Cooper W.O., Hall K., Stein C.M. Out-of-hospital mortality among patients receiving methadone for noncancer pain. JAMA Intern. Med. 2015, 175:420-427.
17. Madden M.E., Shapiro S.L. The methadone epidemic: methadone-related deaths on the rise in Vermont. Am. J. Forensic Med. Pathol. 2011, 32:131-135.
18. Vital signs: risk for overdose from methadone used for pain relief-United States, 1999-2010. MMWR Morb. Mortal. Wkly. Rep. 2012, 61:493-497.
19. Agarin T., Trescot A.M., Agarin A., Lesanics D., Decastro C. Reducing opioid analgesic deaths in America: what health providers can do. Pain Physician 2015, 18:E307-E322.
20. Nuckols T.K., Anderson L., Popescu I., et al. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann. Inter. Med. 2014, 160:38-47.
21. Sims S.A., Snow L.A., Porucznik C.A. Surveillance of methadone-related adverse drug events using multiple public health data sources. J. Biomed. Inform. 2007, 40:382-389.